QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS, DEPENDING ON MEDICO-SOCIAL, ETHNIC CHARACTERISTICS AND PSYCHO-EMOTIONAL STATE (DEPRESSION AND ANXIETY)

Introduction: Systemic lupus erythematosus (SLE) is a disease of uncertain origin, characterized by a wide range of clinical manifestations and affection of various organ systems. A number of authors note that the treatment of SLE should focus not only on improving clinical indicators, but also on the quality components of the patient's well-being, namely, improving the quality of life associated with health.

Objective: to evaluate the quality of life in patients with SLE of the city of Semey, depending on the psycho-emotional state, medico-social and ethnic characteristics.


Bakytzhan E. Konabekov 1,

Yeldos A. Khamitov 2,

Zaytuna A. Khismetova 3, http://orcid.org/0000-0001-5937-3045

 

1 Master's student of the second year of study, specialty "Public Health";

2 PhD student of the second year of study, specialty "Public Health";

3 Lecturer of the public health department, c.m.s.

Department of Public Health,

Semey State Medical University,

Semey, Republic of Kazakhstan.


Литература:

1. Подчерняева Н.С. и др. Системная красная волчанка // Педиатрическая фармакология. 2006. Т. 6. С. 21–26.

2. Björk M. et al. Quality of life and acquired organ damage are intimately related to activity limitations in patients with systemic lupus erythematosus // BMC Musculoskelet. Disord. 2015. Т. 16. № 1.

3. Chaigne B. et al. Impact of disease activity on health-related quality of life in systemic lupus erythematosus – a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS) // BMC Immunol. 2017. Т. 18. № 1. С. 17.

4. Demakakos P. et al. Socioeconomic status and health: the role of subjective social status // Soc. Sci. Med. 2008. Т. 67. № 2. С. 330–40.

5. Doria A. et al. Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants // Rheumatology. 2004. Т. 43. № 12. С. 1580–1586.

6. Etchegaray-Morales I. et al. Factors Associated with Health-Related Quality of Life in Mexican Lupus Patients Using the LupusQol // PLoS One. 2017. Т. 12. № 1. С. e0170209.

7. García-Carrasco M. et al. Health related quality of life in Mexican women with systemic lupus erythematosus: a descriptive study using SF-36 and LupusQoL(C) // Lupus. 2012. Т. 21. № 11. С. 1219–24.

8. George A. et al. Influence of Education on Disease Activity and Damage in Systemic Lupus Erythematosus: Data Fr om the 1000 Canadian Faces of Lupus // Arthritis Care Res. (Hoboken). 2017. Т. 69. № 1. С. 124–132.

9. Golder V. et al. Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study. // Arthritis Res. Ther. 2017. Т. 19. № 1. С. 62.

10. Gordon C. et al. British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults // Rheumatol. 2017. Т. epub. № 6 October. С. 1–45, Suppl.

11. Jolly M. et al. LupusQoL-US benchmarks for US patients with systemic lupus erythematosus // J. Rheumatol. 2010. Т. 37. № 9. С. 1828–1833.

12. Karimi M., Brazier J. Health, Health-Related Quality of Life, and Quality of Life: What is the Difference? // Pharmacoeconomics. 2016. Т. 34. № 7. С. 645–649.

13. Lago S. et al. Socioeconomic status, health inequalities and non-communicable diseases: a systematic review // Z. Gesundh. Wiss. 2018. Т. 26. № 1. С. 1–14.

14. Mazzoni D., Cicognani E., Prati G. Health-related quality of life in systemic lupus erythematosus: a longitudinal study on the impact of problematic support and self-efficacy // Lupus. 2017. Т. 26. № 2. С. 125–131.

15. McElhone K. et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus // Arthritis Rheum. 2007. Т. 57. № 6. С. 972–9.

16. McElhone K. et al. The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosus // J. Rheumatol. 2010. Т. 37. № 11. С. 2273–2279.

17. Mendoza-Pinto C. et al. Socioeconomic status and organ damage in Mexican systemic lupus erythematosus women // Lupus. 2015. Т. 24. № 11. С. 1227–1232.

18. Nasonov E. et al. The prevalence and incidence of Systemic Lupus Erythematosus (SLE) in selected cities fr om three Commonwealth of Independent States countries (the Russian Federation, Ukraine and Kazakhstan) // Lupus. 2014. Т. 23. С. 213–219.

19. Ng P., Chan W. Group psychosocial program for enhancing psychological well-being of people with systemic lupus erythematosus // J Soc Work Disabil Rehabil. 2007. Т. 6. № 3. С. 75–87.

20. Ng X. et al. Understanding systemic lupus erythematosus patients’ desired outcomes and their perceptions of the risks and benefits of using corticosteroids // Lupus. 2017. Т. 0. С. 1–9.

21. Präg P., Mills M.C., Wittek R. Subjective socioeconomic status and health in cross-national comparison // Soc. Sci. Med. 2016. Т. 149. С. 84–92.

22. Rees F. et al. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies // Rheumatology. 2017. C.1-17

23. Semyonov M., Lewin-Epstein N., Maskileyson D. Wh ere wealth matters more for health: The wealth-health gradient in 16 countries // Soc. Sci. Med. 2013. Т. 81. С. 10–17.

24. Shen B. et al. The correlations of disease activity, socioeconomic status, quality of life, and depression/anxiety in Chinese patients with systemic lupus erythematosus // Clin. Dev. Immunol. 2013. Т. 2013. С. 270878.

25. Strand V. et al. Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials // Ann Rheum Dis. 2014. Т. 73. С. 838–844.

26. Tam L.-S. et al. The relationship between neuropsychiatric, clinical, and laboratory variables and quality of life of Chinese patients with systemic lupus erythematosus // J. Rheumatol. 2008. Т. 35. № 6. С. 1038–45.

27. Tamayo T. et al. Factors influencing the health related quality of life in patients with systemic lupus erythematosus: long-term results (2001—2005) of patients in the German Lupus Erythematosus Self-Help Organization (LULA Study) // Lupus. 2010. Т. 19. № 14. С. 1606–1613.

28. Zeng F. et al. Relatives’ quality of life and psychological disturbance: a new concern of SLE management // Clin. Rheumatol. 2017. С. 1–7.

29. Zigmond A.S., Snaith R.P. The Hospital Anxiety and Depression Scale // Acta Psychiatr. Scand. 1983. Т. 67. № 6. С. 361–370.

 

References:

1. Podchernyaeva N.S. et al. Sistemnaya krasnaya volchanka [Systemic lupus erythematous]. Pediatricheskaya farmokologiya [Pediatric pharmacology]. 2006. T. 6. pp. 21–26. [In Russian]

2. Björk M. et al. Quality of life and acquired organ damage are intimately related to activity limitations in patients with systemic lupus erythematosus. BMC Musculoskelet. Disord. 2015. T. 16. № 1.

3. Chaigne B. et al. Impact of disease activity on health-related quality of life in systemic lupus erythematosus – a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS). BMC Immunol. 2017. T. 18. № 1. S. 17.

4. Demakakos P. et al. Socioeconomic status and health: the role of subjective social status. Soc. Sci. Med. 2008. T. 67. № 2. S. 330–40.

5. Doria A. et al. Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants. Rheumatology. 2004. T. 43. № 12. S. 1580–1586.

6. Etchegaray-Morales I. et al. Factors Associated with Health-Related Quality of Life in Mexican Lupus Patients Using the LupusQol. PLoS One. 2017. T. 12. № 1. S. e0170209.

7. García-Carrasco M. et al. Health related quality of life in Mexican women with systemic lupus erythematosus: a descriptive study using SF-36 and LupusQoL(C). Lupus. 2012. T. 21. № 11. S. 1219–24.

8. George A. и др. Influence of Education on Disease Activity and Damage in Systemic Lupus Erythematosus: Data From the 1000 Canadian Faces of Lupus. Arthritis Care Res. (Hoboken). 2017. Т. 69. № 1. С. 124–132.

9. Golder V. et al. Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study. Arthritis Res. Ther. 2017. T. 19. № 1. S. 62.

10. Gordon C. et al. British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatol. 2017. T. epub. № 6 October. S. 1–45, Suppl.

11. Jolly M. et al. LupusQoL-US benchmarks for US patients with systemic lupus erythematosus. J. Rheumatol. 2010. T. 37. № 9. S. 1828–1833.

12. Karimi M., Brazier J. Health, Health-Related Quality of Life, and Quality of Life: What is the Difference? Pharmacoeconomics. 2016. T. 34. № 7. S. 645–649.

13. Lago S. et al. Socioeconomic status, health inequalities and non-communicable diseases: a systematic review. Z. Gesundh. Wiss. 2018. T. 26. № 1. S. 1–14.

14. Mazzoni D., Cicognani E., Prati G. Health-related quality of life in systemic lupus erythematosus: a longitudinal study on the impact of problematic support and self-efficacy. Lupus. 2017. T. 26. № 2. S. 125–131.

15. McElhone K. et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum. 2007. T. 57. № 6. S. 972–9.

16. McElhone K. et al. The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosus. J. Rheumatol. 2010. T. 37. № 11. S. 2273–2279.

17. Mendoza-Pinto C. et al. Socioeconomic status and organ damage in Mexican systemic lupus erythematosus women. Lupus. 2015. T. 24. № 11. S. 1227–1232.

18. Nasonov E. et al. The prevalence and incidence of Systemic Lupus Erythematosus (SLE) in selected cities from three Commonwealth of Independent States countries (the Russian Federation, Ukraine and Kazakhstan). Lupus. 2014. T. 23. S. 213–219.

19. Ng P., Chan W. Group psychosocial program for enhancing psychological well-being of people with systemic lupus erythematosus. J Soc Work Disabil Rehabil. 2007. T. 6. № 3. S. 75–87.

20. Ng X. et al. Understanding systemic lupus erythematosus patients’ desired outcomes and their perceptions of the risks and benefits of using corticosteroids. Lupus. 2017. T. 0. S. 1–9.

21. Präg P., Mills M.C., Wittek R. Subjective socioeconomic status and health in cross-national comparison // Soc. Sci. Med. 2016. T. 149. S. 84–92.

22. Rees F. et al. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology. 2017. S.1-17

23. Semyonov M., Lewin-Epstein N., Maskileyson D. Wh ere wealth matters more for health: The wealth-health gradient in 16 countries. Soc. Sci. Med. 2013. T. 81. S. 10–17.

24. Shen B. et al. The correlations of disease activity, socioeconomic status, quality of life, and depression/anxiety in Chinese patients with systemic lupus erythematosus. Clin. Dev. Immunol. 2013. T. 2013. S. 270878.

25. Strand V. et al. Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials. Ann Rheum Dis. 2014. T. 73. S. 838–844.

26. Tam L.-S. et al. The relationship between neuropsychiatric, clinical, and laboratory variables and quality of life of Chinese patients with systemic lupus erythematosus. J. Rheumatol. 2008. T. 35. № 6. S. 1038–45.

27. Tamayo T. et al. Factors influencing the health related quality of life in patients with systemic lupus erythematosus: long-term results (2001—2005) of patients in the German Lupus Erythematosus Self-Help Organization (LULA Study). Lupus. 2010. T. 19. № 14. S. 1606–1613.

28. Zeng F. et al. Relatives’ quality of life and psychological disturbance: a new concern of SLE management. Clin. Rheumatol. 2017. S. 1–7.

29. Zigmond A.S., Snaith R.P. The Hospital Anxiety and Depression Scale. Acta Psychiatr. Scand. 1983. T. 67. № 6. S. 361–370.

: 936


Конабеков Б.Е., Хамитов Е.А., Хисметова З.А. Качество жизни у пациентов с системной красной волчанкой в зависимости от медико-социальных, этнических характеристик и психоэмоционального состояния (депрессия и тревога) / / Наука и Здравоохранение. 2018. 2 (Т.20). С. 17-28.

Konabekov B.E., Khamitov Ye.A., Khismetova Z.A. Quality of life in patients with systemic lupus erythematosus, depending on medico-social, ethnic characteristics and psycho-emotional state (depression and anxiety). Nauka i Zdravookhranenie [Science & Healthcare]. 2018, (Vol.20) 2, pp. 17-28.

Конабеков Б.Е., Хамитов Е.А., Хисметова З.А. Жүйелі қызыл жегімен ауыратын науқастардың медициналық-әлеуметтік, этникалық сипаттамаларына және психо-эмоционалдық жағдайына (депрессия және үрей) байланысты өмір сүру сапасы / / Ғылым және Денсаулық сақтау. 2018. 2 (Т.20). Б. 17-28.